Journal article
Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine: a population-based cohort study
Abstract
BACKGROUND: Donepezil, rivastigmine and galantamine are popular cholinesterase inhibitors used to manage the symptoms of Alzheimer disease and other dementias; regulatory agencies in several countries warn about a possible risk of rhabdomyolysis with donepezil, based on information from case reports. Our goal was to investigate the 30-day risk of admission to hospital with rhabdomyolysis associated with initiating donepezil versus other …
Authors
Fleet JL; McArthur E; Patel A; Weir MA; Montero-Odasso M; Garg AX
Journal
Canadian Medical Association Journal, Vol. 191, No. 37, pp. e1018–e1024
Publisher
Joule
Publication Date
September 16, 2019
DOI
10.1503/cmaj.190337
ISSN
0820-3946